LGC Capital Completes $8 Million Bought-Deal Private Placement

Montreal, Québec – February 16, 2018 – LGC Capital Ltd. (TSXV: LG) (“LGC) is pleased to announce that it has completed its previously-announced bought-deal private placement, including a partial exercise of the underwriter’s option, by issuing 18,515,000 units at a price of $0.435 per unit for gross proceeds to LGC of $8,054,025.  The units were sold to “accredited investors” in Canada and internationally through Cormark Securities Inc. as underwriter.  Each of the units is comprised of one common share and one common share purchase warrant.  Each full warrant entitles its holder to subscribe for one additional LGC common share at an exercise price of $0.49 for 36 months from the closing date.  In the event that the volume weighted average trading price of LGC’s shares on the TSX Venture Exchange for a period of 20 consecutive trading days commencing four months from the closing date is at least $0.65, LGC will be entitled to send a notice to the holders of the warrants accelerating the expiry date of the warrants to a date not less than 30 trading days after the date of such notice.

As previously announced, LGC will use the net proceeds from the private placement to meet its obligations within LGC’s current cannabis investment portfolio, for further investments, and for working capital.

John McMullen, CEO of LGC commented, “LGC would like to thank the banking and legal teams for their tireless efforts to close this funding into LGC from a major international institutional investor in the global cannabis sector.  We now have more than CAD $16,400,000 cash on hand and are well funded to execute our already announced growth strategy with respect to current investments and build-outs.  This new funding adds considerable financial capabilities for LGC to seek additional investments for our portfolio in the legalized medical cannabis sector globally, with the intended focus of leading to revenue-generating activities for LGC and its shareholders.”

At closing, LGC paid a cash commission to Cormark Securities, as underwriter, in an amount equal to 6% of the gross proceeds from the private placement.  In addition, LGC issued 1,110,900 “broker warrants” to Cormark Securities, representing 6% of the number of units issued and sold in the private placement.  Each of the “broker warrants” entitles its holder to purchase one additional unit at the offering price of $0.435 for a period of three years from the closing date of the private placement.

The securities issued at the closing are subject to a “hold period” which expires on June 17, 2018.

In connection with the private placement, each of LGC’s six directors and officers has entered into a Lock-up Agreement with Cormark Securities under which they have agreed not to sell any LGC common shares or any securities convertible or exchangeable into LGC common shares for a period of 120 days from the closing date of the private placement without the prior consent of Cormark Securities, subject to limited exceptions.

LGC also announces that it has loaned an aggregate of $210,328 to three of LGC’s directors and/or officers in order to fund the exercise by them of LGC stock options and an additional $442,853 to fund the payment by them of related taxes.  The loans, which do not bear interest, must be repaid within two years and are subject to approval by the TSX Venture Exchange.

This news release does not constitute an offer to sell or a solicitation of an offer to buy any of the securities described herein, and these securities will not be offered or sold in any jurisdiction in which their offer or sale would be unlawful. The securities have not been and will not be registered under the United States Securities Act of 1933, as amended (the “1933 Act”), or any state securities laws of the United States.  Accordingly, these securities will not be offered or sold to persons within the United States unless an exemption from the registration requirements of the 1933 Act and applicable state securities laws is available.


About LGC (http://www.lgc-capital.com)

LGC Capital Ltd. is a Canadian incorporated public company listed on the TSX Venture Exchange (TSXV: LG).  LGC’s objective is to become a diversified business group with core business divisions that provide shareholders with exposure to a diverse range of businesses, products and services.

For further information:

Company Contacts:
Canada Contact:
John McMullen, Chief Executive Officer
Tel: +1(416) 803-0698
Email: John@lgc-capital.com

London contact:
Anthony Samaha, Chief Financial Officer
Tel.: +44 (0) 20 7440 0640

Investor Relations contact:
The Howard Group Inc.
Dave Burwell, Vice President
Tel: +1(403) 221-9015
Toll-Free in Canada: 1-888-221-0915,
Email: dave@howardgroupinc.com

FORWARD-LOOKING STATEMENTS
This press release may contain forward-looking statements with respect to LGC Capital Ltd. (“LGC”) and Habi Pharma Pty Ltd (“Habi Pharma”), and their respective operations, strategy, investments, financial performance and condition. These statements generally can be identified by use of forward- looking words such as “may”, “will”, “expect”, “estimate”, “anticipate”, “intends”, “believe” or “continue” or the negative thereof or similar variations. The actual results and performance of LGC and Habi Pharma could differ materially from those expressed or implied by such statements. Such statements are qualified in their entirety by the inherent risks and uncertainties surrounding future expectations. Some important factors that could cause actual results to differ materially from expectations include, among other things, general economic and market factors, competition, government regulation and the factors described under “Risk Factors and Risk Management” in LGC’s Management’s Discussion and Analysis for the fiscal year ended September 30, 2017, as filed on SEDAR (www.sedar.com). The cautionary statements qualify all forward-looking statements attributable to LGC and persons acting on its behalf. Unless otherwise stated, all forward-looking statements speak only as of the date of this press release and neither LGC nor Habi Pharma has any obligation to update such statements, except to the extent required by applicable securities laws.

Caution Regarding Press Releases
Neither the TSX Venture Exchange nor its Regulation Service Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

LGC Capital Increases Strategic Interest in Australian Medical Cannabis Company – Little Green Pharma

MONTREALFeb. 15, 2018 – LGC Capital Ltd. (TSXV: LG) (LGCis pleased to announce that it yesterday completed its previously-announced transaction with licenced Australian Medical Cannabis company Habi Pharma Pty Ltd of Perth, Australia, doing business as Little Green Pharma (“Little Green Pharma“), whereby LGC increased its strategic interest in Little Green Pharma to 14.99% from 11.91%.

John McMullen, CEO of LGC commented, “We are very much looking forward to Little Green Pharma cultivating its first crop over the coming months and producing its first medical cannabis products for commercial sale in Australia.  The funding provided by LGC over the past few months has provided Little Green Pharma with working capital to enable it to start its first commercial production.  LGC’s objective is to fund many of our other investment initiatives around the world to achieve the same goal over the coming year.”

At closing, Little Green Pharma issued 2,283,495 additional shares to LGC at a deemed issue price of AUD $1.16398 per share for a total consideration of approximately AUD $2,657,950.  LGC paid for the shares by issuing 5,000,000 LGC shares to Little Green Pharma at a deemed issue price of CAD $0.53 per share, representing the closing price of LGC’s shares on the TSX Venture Exchange on January 19, 2018, for a total consideration of CAD $2,650,000, equivalent to AUD $2,679,150 based on the Bank of Canada exchange rate on February 14, 2018.  The 5,000,000 LGC shares are subject to a “hold period” which expires on June 15, 2018.

The subscription agreement entered into by LGC and Little Green Pharma at closing contains an undertaking by LGC to participate in Little Green Pharma’s next capital raise, by June 30, 2018, to the extent required to maintain LGC’s 14.99% shareholding in Little Green Pharma.

Note: On February 14, 2018, the Bank of Canada’s daily average exchange rate for the Australian dollar was AUD $1.00 = CAD $0.9891.

About Little Green Pharma (www.lgpharma.com.au)

Little Green Pharma is a private entity in Australia and is one of the few companies in Australia to be granted a licence to cultivate and produce Medical Cannabis within Australia. On December 14, 2017, Little Green Pharma announced that its first crop of medicinal cannabis was being cultivated in Western Australia at its secure growing facility south of Perth. That event marks the first time medicinal cannabis has been cultivated locally in Western Australia. Little Green Pharma aims to have first product available for patients within the first few months of 2018.

About LGC (http://www.lgc-capital.com)

LGC Capital Ltd. is a Canadian incorporated public company listed on the TSX Venture Exchange (TSXV: LG). LGC’s objective is to become a diversified business group with core business divisions that provide shareholders with exposure to a diverse range of businesses, products and services.


For further information:

Company Contacts:
Canada Contact:
John McMullen, Chief Executive Officer
Tel: +1(416) 803-0698
Email: John@lgc-capital.com

London contact:
Anthony Samaha, Chief Financial Officer
Tel.: +44 (0) 20 7440 0640

Investor Relations contact:
The Howard Group Inc.
Dave Burwell, Vice President
Tel: +1(403) 221-9015
Toll-Free in Canada: 1-888-221-0915,
Email: dave@howardgroupinc.com

FORWARD-LOOKING STATEMENTS
This press release may contain forward-looking statements with respect to LGC Capital Ltd. (“LGC”) and Habi Pharma Pty Ltd (“Habi Pharma”), and their respective operations, strategy, investments, financial performance and condition. These statements generally can be identified by use of forward- looking words such as “may”, “will”, “expect”, “estimate”, “anticipate”, “intends”, “believe” or “continue” or the negative thereof or similar variations. The actual results and performance of LGC and Habi Pharma could differ materially from those expressed or implied by such statements. Such statements are qualified in their entirety by the inherent risks and uncertainties surrounding future expectations. Some important factors that could cause actual results to differ materially from expectations include, among other things, general economic and market factors, competition, government regulation and the factors described under “Risk Factors and Risk Management” in LGC’s Management’s Discussion and Analysis for the fiscal year ended September 30, 2017, as filed on SEDAR (www.sedar.com). The cautionary statements qualify all forward-looking statements attributable to LGC and persons acting on its behalf. Unless otherwise stated, all forward-looking statements speak only as of the date of this press release and neither LGC nor Habi Pharma has any obligation to update such statements, except to the extent required by applicable securities laws.

Caution Regarding Press Releases
Neither the TSX Venture Exchange nor its Regulation Service Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

LGC Capital Completes US$2.34 Million Convertible Loan Transaction to Fund Business Expansion

MONTREALFeb. 8, 2018 – LGC Capital Ltd. (TSXV: LG) (“LGC“) is pleased to announce that it has now completed its previously-announced transaction with international investors YA II PN, Ltd and Cuart Investments PCC Limited pursuant to which they loaned an aggregate amount of US $2.34 million (approximately CAD $2.94 million) to LGC at a closing held today.

John McMullen, LGC Capital’s CEO commented; “LGC intends to use these proceeds to further advance its core business divisions on its global platform and seek new acquisitions and investment opportunities that are synergistic with LGC’s current focus.”

The loan has a term of twelve months and bears interest at an annual rate of 9.5%, payable quarterly in arrears.  The principal amount of the loan is convertible into LGC common shares at the option of the lenders at a price per share equal to the lesser of (i) US $0.538 (CAD $0.675), representing the US dollar equivalent of 135% of the closing price of LGC’s shares on the TSX Venture Exchange on December 29, 2017 (CAD $0.50), and (ii) 90% of the lowest daily volume weighted average trading price of LGC’s shares during the five trading days immediately preceding the date of a conversion notice from the lenders, subject to a minimum conversion price of CAD $0.50.

At closing, LGC issued an aggregate of 1,643,764 common share purchase warrants to the two lenders, representing an amount equal to 25% of the dollar amount of the loan divided by CAD $0.4465, being the volume weighted average trading price of LGC’s shares during the five trading days ended December 29, 2017.  Each warrant entitles its holder to acquire one common share of LGC at a price of CAD $0.70, representing 140% of LGC’s closing price on December 29, 2017, for a period of one year from the date of issuance.

In connection with the Investment Agreement, LGC paid a cash due diligence fee to RiverFort Global Capital Ltd. (“RiverFort”) of London, England.  At closing, LGC also paid a structuring fee to RiverFort by issuing 376,162 shares to it, representing an amount equal to 12.5% of the dollar amount of loan from YA II PN, Ltd, less the amount of the due diligence fee, divided by CAD $0.675, representing 135% of the closing price of LGC’s shares on the TSX Venture Exchange on December 29, 2017 (CAD $0.50).

The securities issued at the closing are subject to a “hold period” which expires on June 9, 2018.  LGC is at arm’s length from the two lenders and RiverFort.

About LGC (http://www.lgc-capital.com):

LGC Capital Ltd. is a Canadian incorporated public company listed on the TSX Venture Exchange (TSXV: LG). LGC’s objective is to become a diversified business group with core business divisions that provide shareholders with exposure to a diverse range of businesses, products and services.

For further information:

Company Contacts:

Canada contact: John McMullen, Chief Executive Officer
Tel.: (416) 803-0698;
Email: john@lgc-capital.com
Anthony Samaha, Chief Financial Officer (London)
Tel.: +44 (0) 20 7440 0640

Investor Relations Contact:

Dave Burwell, The Howard Group Inc.
Tel.: (403) 221-9015
Toll Free: 1-888-221-0915
Email: dave@howardgroupinc.com

FORWARD-LOOKING STATEMENTS:

This press release may contain forward-looking statements with respect to LGC Capital Ltd. (“LGC”), its operations, strategy, investments, financial performance and condition, and the Investment Agreement referred to above. These statements generally can be identified by use of forward-looking words such as “may”, “will”, “expect”, “estimate”, “anticipate”, “intends”, “believe” or “continue” or the negative thereof or similar variations. The actual results and performance of LGC could differ materially from those expressed or implied by such statements. Such statements are qualified in their entirety by the inherent risks and uncertainties surrounding future expectations. Some important factors that could cause actual results to differ materially from expectations include, among other things, general economic and market factors, competition, government regulation and the factors described under “Risk Factors and Risk Management” in LGC’s Management’s Discussion and Analysis for the fiscal year ended September 30, 2017, as filed on SEDAR (www.sedar.com). The cautionary statements qualify all forward-looking statements attributable to LGC and persons acting on its behalf. Unless otherwise stated, all forward-looking statements speak only as of the date of this press release and LGC has no obligation to update such statements, except to the extent required by applicable securities laws.

Caution Regarding Press Releases:

Neither the TSX Venture Exchange nor its Regulation Service Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Canada Jetlines Appoints Former Spirit Airlines Senior Executive as Independent Director and Key Talent to Advisory Board

VANCOUVER, British Columbia, Feb. 06, 2018 (GLOBE NEWSWIRE) — Canada Jetlines Ltd. (TSX-V:JET) (OTCQB:JETMF) (the “Company” or “Jetlines”) is pleased to announce the appointment of Tony Lefebvre as an independent director, effective February 5, 2018. Mr. Lefebvre brings over 27 years of executive experience, including eight years with Spirit Airlines, a leading ultra low-cost carrier based in the United States.

“Mr. Lefebvre is a welcome addition to the board,” stated Mark Morabito, Executive Chairman of Canada Jetlines. “His extensive experience in the ultra-low cost airline industry will be invaluable to the company as we commence and grow operations.”

Tony held progressively senior executive positions with Spirit Airlines, most notably Chief Operating Officer. He was responsible for Spirit Airlines operating functions including: flight operations, maintenance, inflight, airport operations, systems operations control, safety and security.  Tony was part of the senior management team that successfully publicly listed the company on the NASDAQ and lead cost cutting initiatives resulting in a sustained sub $0.06 CASM (Cost Per Available Seat Mile). Prior to working with Spirit Airlines, Tony worked with US Airways for 15 years as a Managing Director. In this role he led US Airways’ European operations across 16 countries, covering sales and marketing, 28 airport operations, call centres sales and customer support, finance and alliance management.

Tony is currently President and Chief Operating Officer at BBA Aviation. He is responsible for BBA’s Global Engine Services and Signature MRO businesses, providing flight support services to business aircraft owners, government and commercial aviation customers.

Tony holds a Bachelor of Science in Business Administration and Marketing from the University of Maryland.

The Company has also appointed Warren Kinsella and Tayfun Eldem to its Advisory Board.

Warren Kinsella is the president of Daisy Group. Previously, he was a partner at the law firm of McMillan Binch, in its Public Policy Group, and has also worked as a consultant, journalist, and political Chief of Staff in Canada. Mr. Kinsella has considerable experience representing the airline industry. For a number of years, he was United Airlines’ chief consultant in Canada. In addition, Mr. Kinsella was the chief government and public relations advisor to the Toronto Port Authority during the period when Porter Airlines was taking off. Mr. Kinsella received a Bachelor of Journalism (Honours) from Carleton University and his law degree from the University of Calgary; he has also completed executive education courses at Harvard’s law school and its school of business.

Tayfun Eldem is a seasoned business executive located in Montreal, Quebec. He has held senior roles with several large multinational organizations. Mr. Eldem has significant experience in operations management, business development, capital markets, government relations, project management and technical marketing. Mr. Eldem was recently reappointed as the Chief Executive Officer of Toronto Stock Exchange listed Alderon Iron Ore Corp. Previously, Mr. Eldem was Managing Director and Associate at Hatch Ltd., leading Hatch’s business development, client engagement and project delivery functions in Eastern North America as well as overseeing the business globally for the iron ore and coal commodities. He previously worked for the Iron Ore Company of Canada, a Rio Tinto subsidiary, for more than 20 years. During this period, Mr. Eldem held many senior roles including Vice President, Expansion Projects & Engineering and COO. Mr. Eldem is a professional engineer who graduated from Dalhousie University.

Jetlines has granted a total of 225,000 stock options to Mr. Lefebvre in his role as a director. The stock options have been issued for a five-year term, with one quarter vesting every six months from the date of grant.

Jetlines also announces the resignation of Mr. Mark Lotz from the Board of Directors and would like to thank him for his significant contribution to the Company’s development to date.

About Canada Jetlines Ltd.

Canada Jetlines is set to become Canada’s first ultra-low cost carrier (ULCC) airline, with plans to operate flights across Canada and provide non-stop service from Canada to the United States, Mexico and the Caribbean. Jetlines is led by a board and management team with extensive experience and expertise in low-cost airlines, start-ups and capital markets. The Company was granted an unprecedented exemption from the Government of Canada that will permit it to conduct domestic air services while having up to 49% foreign voting interests.

For more information on Jetlines, please visit our website at www.jetlines.ca.

ON BEHALF OF THE BOARD

“Mark J. Morabito”
Executive Chairman

Canada Jetlines is part of the King & Bay group of companies. King & Bay is a merchant bank that specializes in identifying, funding, developing and supporting growth opportunities in the resource, aviation, and technology sectors.

For more information, please contact:
The Howard Group Inc.
Tel: (403) 221-0915
Toll Free: 1-888-221-0915
Jeff Walker: jeff@howardgroupinc.com

Cautionary Note Regarding Forward-Looking Information

This news release contains “forward-looking information” concerning anticipated developments and events that may occur in the future. Forward looking information contained in this news release includes, but is not limited to, statements with respect to the airports that Jetlines intends to utilize, the routes that Jetlines intends to fly, Jetlines business plan, Jetlines ability to offer ultra-low fares, and future airline operations of the Company.

In certain cases, forward-looking information can be identified by the use of words such as “plans”, “expects” or “does not expect”, “is expected”, “budget”, “scheduled”, “estimates”, “forecasts”, “intends”, “anticipates” or “does not anticipate”, or “believes”, or variations of such words and phrases or state that certain actions, events or results “may”, “could”, “would”, “might” or “will be taken”, “occur” or “be achieved” suggesting future outcomes, or other expectations, beliefs, plans, objectives, assumptions, intentions or statements about future events or performance. Forward-looking information contained in this news release is based on certain factors and assumptions regarding, among other things, the accuracy, reliability and applicability of the Jetlines’ business model; the timely receipt of governmental approvals, including the receipt of approval from regulators in Canada, the United States, Mexico and other jurisdictions where Jetlines may operate; the timely commencement of operations by Jetlines and the success of such operations; the ability of Jetlines to implement its business plan as intended; the legislative and regulatory environments of the jurisdictions where the Jetlines will carry on business or have operations; the impact of competition and the competitive response to the Jetlines’ business strategy; the completion of financing for airline operations; and the availability of aircraft. While the Company considers these assumptions to be reasonable based on information currently available to it, they may prove to be incorrect.

Forward looking information involves known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of the Company to be materially different from any future results, performance or achievements expressed or implied by the forward-looking information. Such factors include risks related to acts of God, the impact of general economic conditions, changing domestic and international airline industry conditions, volatility of fuel prices, increases in operating costs, terrorism, pandemics, currency fluctuations, interest rates, risks specific to the airline industry, the ability of management to implement Jetlines’ operational strategy, the ability to attract qualified management and staff, labour disputes, regulatory risks, including risks relating to the acquisition of the necessary licenses and permits, financing, capitalization and liquidity risks, including the risk that the financing necessary to fund operations may not be obtained and the additional risks identified in the “Risk Factors” section of the Company’s reports and filings with applicable Canadian securities regulators.

Although the Company has attempted to identify important factors that could cause actual actions, events or results to differ materially from those described in forward-looking information, there may be other factors that cause actions, events or results not to be as anticipated, estimated or intended. Accordingly, readers should not place undue reliance on forward-looking information. The forward-looking information is made as of the date of this news release. Except as required by applicable securities laws, the Company does not undertake any obligation to publicly update or revise any forward-looking information.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) has reviewed or accepts responsibility for the adequacy or accuracy of this release.

 

QYOU and iflix Partner on Major Global Content Initiative

  • iflix, the leading OTT service for emerging markets, to distribute exclusive localized QYOU video programming in 25 global territories reaching a potential audience of over 1 billion
  • Agreement marks major step for QYOU, significantly expanding its global footprint with initial targeted localized formats in Indonesia, Malaysia and Philippines

Dublin/Los Angeles/Toronto 6 February 2018QYOU Media (TSXV: QYOU OTC: QYOUF), the world’s leading curator of premium ‘best-of-web’ video for multiscreen distribution, announced today it has partnered with iflix, the leading subscription OTT service for emerging markets, to distribute QYOU’s curated online video content in 25 global territories. The agreement includes exclusive locally hosted formats on iflix’s service in Indonesia, Malaysia and Philippines.

This represents the first step in a growing distribution collaboration between the two companies to bring unique short form content from local video creators to audiences in emerging markets.

Digital TV Research states that global revenues from SVOD TV and movies is due to reach $41B by 2022. iflix has seen tremendous growth in emerging markets within Asia, the Middle East and Africa, and attributes that success to creating a service for local customers with locally relevant content. iflix has now selected QYOU, as the company’s first short form content partner to help boost its catalogue of regional content. For QYOU, this marks a major step to building further localized offerings around the world, following the success of its local launches in India and Poland last year.

The appetite globally among millennials and Gen-Z for digital first short form video content continues to grow at astonishing rates with over 500 million hours of video watched on YouTube daily. To help iflix capitalize on this appetite and tap further into this market segment, QYOU will curate bespoke video content from local creators in each local market and package this for iflix users around the region.

“We are passionately focused on local customer experiences and are always looking for new ways to deliver authentic culturally relevant, compelling content to our users,” said Sean Carey, Chief Content Officer, iflix Group. “QYOU is a great partner to help us in this quest. They have a proven ability to curate, customize and package the best of short form local online video content for millennial audiences. Introducing exclusive QYOU content to the service in our markets, beginning with Southeast Asia will help further enrich our offering by showcasing some of the best local entertainment the region has to offer.”

“Both of our companies recognize that there is a global shift towards a more culturally relevant and personalized content experience,” said Curt Marvis, CEO and Co-founder of QYOU Media. “This is particularly true for younger audiences who regularly view videos from local creators on social video channels, where the barriers to creating amazing video are so much lower. We are thrilled to partner with iflix, who recognize the importance of delivering curated locally produced content and share our ambitions to bring customers the best content wherever and however they choose to view it.”

About QYOU Media

QYOU Media Inc. is a fast-growing global media company that curates and packages premium ‘best-of-the-web’ video for multiscreen distribution. Founded and created by industry veterans from Lionsgate, MTV, and CinemaNow, QYOU’s millennial-focused products including linear television networks, genre-based series, mobile apps, and video-on-demand formats reach millions of customers on six continents. Distribution partners include Sinclair Broadcast Group, Vodafone, 21st Century Fox, Liberty Global, Telenor and TATA Sky.

ABOUT IFLIX

iflix is the world’s leading entertainment service for emerging markets, offering users unlimited access to thousands of TV shows, movies and more. With a vast selection everyone’s favourite comedies, drama, K-drama, Turkish drama, Bollywood, Nollywood, cartoons, movies, live sports and more from Hollywood, the UK, Asia, The Middle East and Africa, iflix places the entertainment people want at their fingertips to either stream or download. For one low monthly fee, iflix subscribers can watch on their mobile phone, laptop, tablet, TV… wherever, whenever.

Let’s play.

iflix is currently available to consumers in Malaysia, Indonesia, the Philippines, Thailand, Brunei, Sri Lanka, Pakistan, Myanmar, Vietnam, the Maldives, Kuwait, Bahrain, Saudi Arabia, Jordan, Iraq, Lebanon, Egypt, Sudan, Cambodia, Nigeria, Kenya, Ghana, Nepal, Bangladesh and Zimbabwe.

Contacts

Holly Searle                                                                            Natasha Roberton
Platform Communications – for QYOU Media               VP Marketing, QYOU Media
+44 (0) 207 486 4900                                                          +49 152 2254 7680
holly@platformcomms.com                                                tash@qyoutv.com

Jeff Walker,
Investor Relations – for QYOU Media
+ 1 403 221 0915
jeff@howardgroupinc.com

LGC Capital Ltd. Receives TSX Venture Exchange Approval for US $2.34 Million Convertible Loan Agreement

Montreal, Québec – January 31, 2018 LGC Capital Ltd. (TSXV: LG) (“LGC”) is pleased to announce that it has received conditional approval from the TSX Venture Exchange for its previously-announced transaction with international investors YA II PN, Ltd and Cuart Investments PCC Limited pursuant to which they will loan LGC an aggregate amount of US $2.34 million (approximately CAD $2.88 million).  LGC intends to use the net proceeds from the loan to further advance its core business divisions on its global platform.

Closing of the transaction and the advance of funds to LGC is expected to take place shortly, subject to standard closing conditions.

The Investment Agreement between LGC and the two lenders, as amended (the “Investment Agreement”), provides that the loan will have a term of twelve months and bear interest at an annual rate of 9.5%, payable quarterly in arrears.  The principal amount of the loan will be convertible into LGC common shares at the option of the lenders at a price per share equal to the lesser of (i) US $0.538 (CAD $0.675), representing the US dollar equivalent of 135% of the closing price of LGC’s shares on the TSX Venture Exchange on December 29, 2017 (CAD $0.50), and (ii) 90% of the lowest daily volume weighted average trading price of LGC’s shares during the five trading days immediately preceding the date of a conversion notice from the lenders, subject to a minimum conversion price of CAD $0.50.

Upon each advance of funds under the Investment Agreement, LGC will issue common share purchase warrants to the lenders in an amount equal to 25% of the dollar amount of the advance divided by CAD $0.4465, being the volume weighted average trading price of LGC’s shares during the five trading days ended December 29, 2017.  Each warrant will entitle its holder to acquire one common share of LGC at a price of CAD $0.70, representing 140% of LGC’s closing price on December 29, 2017, for a period of one year from the date of issuance.

In connection with the Investment Agreement, LGC will pay a cash due diligence fee to RiverFort Global Capital Ltd. (“RiverFort”) of London, England.  LGC will also pay a structuring fee to RiverFort by issuing shares to it in an amount equal to 12.5% of the dollar amount of any advance of the loan by YA II PN, Ltd, less the amount of the due diligence fee, divided by CAD $0.675, representing 135% of the closing price of LGC’s shares on the TSX Venture Exchange on December 29, 2017 (CAD $0.50).  The shares will be issued on the date of the advance of the loan.

Any securities issued by LGC at the closing of the transaction, as well as any shares issued upon conversion of the loan or upon the exercise of warrants, will be subject to restrictions on resale for a period of four months from the closing date of the transaction.  LGC is at arm’s length from the lenders and RiverFort.

About LGC (http://www.lgc-capital.com):

LGC Capital Ltd. is a Canadian incorporated public company listed on the TSX Venture Exchange (TSXV: LG). LGC’s objective is to become a diversified business group with core business divisions that provide shareholders with exposure to a diverse range of businesses, products and services.

For further information:

Company Contacts:

Canada contact: John McMullen, Chief Executive Officer
Tel.: (416) 803-0698;
Email: john@lgc-capital.com
Anthony Samaha, Chief Financial Officer (London)
Tel.: +44 (0) 20 7440 0640

Investor Relations Contact:

Dave Burwell, The Howard Group Inc.
Tel.: (403) 221-9015
Toll Free: 1-888-221-0915
Email: dave@howardgroupinc.com

FORWARD LOOKING STATEMENTS:

This press release may contain forward-looking statements with respect to LGC Capital Ltd. (“LGC”), its operations, strategy, investments, financial performance and condition, and the Investment Agreement referred to above. These statements generally can be identified by use of forward-looking words such as “may”, “will”, “expect”, “estimate”, “anticipate”, “intends”, “believe” or “continue” or the negative thereof or similar variations. The actual results and performance of LGC could differ materially from those expressed or implied by such statements. Such statements are qualified in their entirety by the inherent risks and uncertainties surrounding future expectations. Some important factors that could cause actual results to differ materially from expectations include, among other things, general economic and market factors, competition, government regulation and the factors described under “Risk Factors and Risk Management” in LGC’s Management’s Discussion and Analysis for the fiscal year ended September 30, 2017, as filed on SEDAR (www.sedar.com). The cautionary statements qualify all forward-looking statements attributable to LGC and persons acting on its behalf. Unless otherwise stated, all forward-looking statements speak only as of the date of this press release and LGC has no obligation to update such statements, except to the extent required by applicable securities laws.

Caution Regarding Press Releases:

Neither the TSX Venture Exchange nor its Regulation Service Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Canada Jetlines Appoints Industry Experts to Lead Flight Operations and Maintenance Teams

Canada Jetlines Ltd. (TSX-V: JET) (the “Company” or “Jetlines”) is pleased to announce the appointments of Captain Vic Charlebois as Vice President Flight Operations and Phil Larsen as Vice President Maintenance effective immediately. Mr. Charlebois and Mr. Larsen will report directly to CEO, Stan Gadek.

Having built an aviation career including nearly twenty years with the Canadian Forces, as well as serving as VP Flight Operations for First Air, Zoom Airlines and Canada 3000, Mr. Charlebois will have responsibility for all pilot, flight attendant, flight dispatch, systems operations control and training functions throughout the airline.

Stan Gadek said, “Vic is truly a pilot’s pilot. He is highly experienced with multiple type ratings in large transport category aircraft such as the Boeing 757/767 and Airbus A320/330, as well as numerous military large piston, turbine and turbojet aircraft. I am delighted to have Vic leading our flight operations department.”

Vic commented, “I am eager to join the Jetlines team and help build the next celebrated airline of Canada. This is a significant honour and I look forward to working with our Transport Canada Certification Team and building a safe, compliant flight operations department that will be a core asset to Canada Jetlines’ success.”

Gadek continued, “Phil Larsen is another exceptional example of aviation leadership. With over twenty years’ experience in senior roles in maintenance, engineering and technical services, at Canadian Airlines International, Air Canada, and CHC Global Operations Group, Phil is the ideal person for this role. I am privileged to have him lead our technical operations as we continue to bring Jetlines to operational status.”

Phil stated, “I look forward to working with a great team and being part of launching Canada Jetlines, a true ULCC airline in Canada as a safe, affordable new service.”

Gadek went on to say, “I am excited and proud that Vic and Phil are coming on board. I know that with their leadership we will build an organization that people will want to be a part of and our customers will want to fly.”

Jetlines has granted a combined total of 450,000 stock options to Mr. Charlebois and Mr. Larsen. The stock options have been issued for a five-year term, with one quarter vesting every six months from the date of grant.

About Canada Jetlines Ltd.
Canada Jetlines is set to become Canada’s first ultra-low cost carrier (ULCC) airline, with plans to operate flights across Canada and provide non-stop service from Canada to the United States, Mexico and the Caribbean. Jetlines is led by a board and management team with extensive experience and expertise in low-cost airlines, start-ups and capital markets. The Company was granted an unprecedented exemption from the Government of Canada that will permit it to conduct domestic air services while having up to 49% foreign voting interests.

For more information on Jetlines, please visit our website at www.jetlines.ca.

ON BEHALF OF THE BOARD

“Mark J. Morabito”
Executive Chairman

Canada Jetlines is part of the King & Bay group of companies. King & Bay is a merchant bank that specializes in identifying, funding, developing and supporting growth opportunities in the resource, aviation, and technology sectors.

For Investor Relations please call: 
The Howard Group Inc.
Tel: (403) 221-0915
Toll Free: 1-888-221-0915
Jeff Walker: jeff@howardgroupinc.com

Cautionary Note Regarding Forward-Looking Information
This news release contains “forward-looking information” concerning anticipated developments and events that may occur in the future. Forward looking information contained in this news release includes, but is not limited to, statements with respect to the airports that Jetlines intends to utilize, the routes that Jetlines intends to fly, Jetlines business plan, the timelines for ticket sales and the start of airline operations, Jetlines ability to offer ultra-low fares, and future airline operations of the Company.

In certain cases, forward-looking information can be identified by the use of words such as “plans”, “expects” or “does not expect”, “is expected”, “budget”, “scheduled”, “estimates”, “forecasts”, “intends”, “anticipates” or “does not anticipate”, or “believes”, or variations of such words and phrases or state that certain actions, events or results “may”, “could”, “would”, “might” or “will be taken”, “occur” or “be achieved” suggesting future outcomes, or other expectations, beliefs, plans, objectives, assumptions, intentions or statements about future events or performance. Forward-looking information contained in this news release is based on certain factors and assumptions regarding, among other things, the accuracy, reliability and applicability of the Jetlines’ business model; the timely receipt of governmental approvals, including the receipt of approval from regulators in Canada, the United States, Mexico and other jurisdictions where Jetlines may operate; the timely commencement of operations by Jetlines and the success of such operations; the ability of Jetlines to implement its business plan as intended; the legislative and regulatory environments of the jurisdictions where the Jetlines will carry on business or have operations; the impact of competition and the competitive response to the Jetlines’ business strategy; the completion of financing for airline operations; and the availability of aircraft. While the Company considers these assumptions to be reasonable based on information currently available to it, they may prove to be incorrect.

Forward looking information involves known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of the Company to be materially different from any future results, performance or achievements expressed or implied by the forward-looking information. Such factors include risks related to acts of God, the impact of general economic conditions, changing domestic and international airline industry conditions, volatility of fuel prices, increases in operating costs, terrorism, pandemics, currency fluctuations, interest rates, risks specific to the airline industry, the ability of management to implement Jetlines’ operational strategy, the ability to attract qualified management and staff, labour disputes, regulatory risks, including risks relating to the acquisition of the necessary licenses and permits, financing, capitalization and liquidity risks, including the risk that the financing necessary to fund operations may not be obtained and the additional risks identified in the “Risk Factors” section of the Company’s reports and filings with applicable Canadian securities regulators.

Although the Company has attempted to identify important factors that could cause actual actions, events or results to differ materially from those described in forward-looking information, there may be other factors that cause actions, events or results not to be as anticipated, estimated or intended. Accordingly, readers should not place undue reliance on forward-looking information. The forward-looking information is made as of the date of this news release. Except as required by applicable securities laws, the Company does not undertake any obligation to publicly update or revise any forward-looking information.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) has reviewed or accepts responsibility for the adequacy or accuracy of this release.

LGC Capital to Expand Global Footprint in Medical Cannabis Market Through Investment in Jamaica’s Global Canna Labs Limited

  • LGC to subscribe for a $2.5 million secured debenture of Jamaican cannabis company Global Canna Labs Limited, convertible into an initial 30% interest, and to acquire a 5% royalty on net sales.
  • The Jamaican Cannabis Licensing Authority granted Global Canna Labs conditional approval for a Cultivator’s Licence (Tier 3) (over 5 acres) on December 20, 2017.
  • Global Canna Labs plans to start cultivation of its first commercial cannabis crop by Q2 2018.
  • Construction of Global Canna Labs’ first dispensary is expected to start in Q1 2018 in Montego Bay’s Hip Strip.
  • Plans are also in place for Global Canna Labs to open an on-site farm store and a dispensary in Kingston, Jamaica by the end of 2018.

Montreal, Québec – January 26, 2018 – LGC Capital Ltd. (TSXV: LG) (“LGC) is pleased to announce that it has signed a Letter of Intent with rapidly-developing Jamaican cannabis company Global Canna Labs Limited (“Global Canna Labs”) for a strategic investment in the Jamaican cannabis market as part of LGC’s ongoing international expansion.

The Letter of Intent with Global Canna Labs and one of its major shareholders provides that LGC will subscribe for a $2.5 million secured debenture, convertible into an initial 30% strategic interest in Global Canna Labs, and will also acquire a 5% royalty on Global Canna Labs’ net sales for $2 million, payable in shares of LGC.

John McMullen, CEO of LGC commented, This exciting transaction with Global Canna Labs will not only extend our global reach within the legalized cannabis industry, it will increase LGC’s investment footprint into the lucrative Caribbean Region. We believe that our investment will assist Global Canna Labs in achieving almost immediate production. The potential square footage, scale and expandability of this operation is significant and we look forward to working closely with Global Canna Labs and its highly-experienced team to build something quite special in Jamaica.”

Global Canna Labs Limited CEO Paul Glavine states; Today is a very significant day for the medical cannabis industry in Jamaica, with LGC today showing its strong financial commitment to jointly building a strong Jamaican brand in-country and on the world stage. Jamaica has for a long time been very well positioned to become a leader in the medical cannabis industry. It has a long, rich and varied culture and a highly motivated population. Global Canna Labs has secured a strong board, highly specialized in security, medicine and business expertise in the country. We have developed deeply rooted ties with the leaders in the local economy, which will allow us to maximize our expected production capacity of 40,000 kg annually through our current Montego Bay facilities as quickly as possible. We are glad to announce this partnership with LGC and we share its Jamaican vision. With 20 years of combined industrial experience in cultivating medical cannabis, we are now focused on rapidly building-out our operations and becoming the largest Caribbean producer of high grade medical cannabis.”

 Transaction Details: (all amounts in Canadian dollars)

The transaction is comprised of two parts:

  • LGC will, by way of a secured convertible debenture (the “Debenture”), invest $2.5 million which will be disbursed in traches in accordance with the achievement of milestones in Global Canna Labs’ business plan; and
  • LGC will purchase a 5% royalty (“Royalty”) on Global Canna Labs’ net sales for $2 million, payable in shares of LGC.

The Debenture will have a four-year term, carry interest at an annual rate of 7%, and be secured by the assets of Global Canna Labs. The Debenture will be convertible into common shares of Global Canna Labs and to be formed Canadian affiliate so as to comply with Jamaican foreign ownership rules, corresponding to a 30% ownership interest in Global Canna Labs. The Debenture will be converted immediately prior to any liquidity event.

The Royalty will also be secured by the assets of Global Canna Labs, which will have the right to repurchase the Royalty for $6 million.

The Letter of Intent provides that LGC will carry out an accelerated due diligence review, to be completed by February 15, 2018, and that upon successful completion of due diligence, the parties will enter into definitive agreements by February 25, 2018.

Closing of the transaction with Global Canna Labs is also subject to the parties entering into definitive agreements and to standard closing conditions. The transaction is subject to regulatory approval, including that of the TSX Venture Exchange.

About Global Canna Labs (http://globalcannalabs.com)

Global Canna Labs is a Jamaican entity with its head office located in Kingston, Jamaica, with operations based in Montego Bay, with plans to become one of the leading cultivators and processors in Jamaica of cannabis for medical and recreational purposes. Target production is expected to total 1,876 kg in 2018 and rising quickly to 7,741 kg annually by 2021. These production targets can be rapidly expanded from current targets should demand exceed supply.

The Montego Bay site comprises a 22-acre plot with an additional 80-acre expansion opportunity on the same plot. The location is only 10 minutes from the Montego Bay airport and sea port providing logistics access for facilitating global exports.

Global Canna Labs is in the final stages of acquiring a full commercial cannabis license in Jamaica enabling clinical trials, dispensaries, recreational sale, and medical export. On December 20, 2017, the Cannabis Licencing Authority of Jamaica granted conditional approval for a Cultivator’s Licence (Tier 3) (over 5 acres).

Construction of its first 58,000 sq. feet of greenhouses is in progress and is nearing completion, with 4 additional acres of outdoor growth and state-of-the-art processing facility meeting GMP and ISO standards in the current site plan. Security fencing around the initial cultivation site covering 6 acres in total has already been installed.

Construction of Global Canna Labs’ first dispensary is expected to start in Q1 2018 in Montego Bay’s Hip Strip. Plans are also in place for Global Canna Labs to open an on-site farm store and its first dispensary in Kingston by the end of 2018.

About LGC (http://www.lgc-capital.com)

LGC Capital Ltd. is a Canadian incorporated public company listed on the TSX Venture Exchange (TSXV: LG). LGC’s objective is to become a diversified business group with core business divisions that provide shareholders with exposure to a diverse range of businesses, products and services.

Information Relating to Global Canna Labs Limited

All information contained in this press release relating to Global Canna Labs Limited has been provided to LGC by Global Canna Labs Limited. LGC has relied upon this information without having made independent inquiries as to its accuracy or completeness and assumes no responsibility for any inaccuracy or incompleteness of such information.

For further information please contact:

John McMullen, Chief Executive Officer
Tel.: (416) 803-0698
Email: John@lgc-capital.com

London contact:
Anthony Samaha, Chief Financial Officer
Tel.: +44 (0) 20 7440 0640

Investor Relations:

Dave Burwell
The Howard Group Inc.
Tel.: (403) 221-9015
Toll Free: 1-888-221-0915
Email: dave@howardgroupinc.com

FORWARD LOOKING STATEMENTS

This press release may contain forward-looking statements with respect to LGC Capital Ltd. (“LGC”) and Global Canna Labs Limited, and their respective operations, strategy, investments, financial performance and condition. These statements generally can be identified by use of forward- looking words such as “may”, “will”, “expect”, “estimate”, “anticipate”, “intends”, “believe” or “continue” or the negative thereof or similar variations. The actual results and performance of LGC and Global Canna Labs Limited could differ materially from those expressed or implied by such statements. Such statements are qualified in their entirety by the inherent risks and uncertainties surrounding future expectations. Some important factors that could cause actual results to differ materially from expectations include, among other things, general economic and market factors, competition, government regulation and the factors described under “Risk Factors and Risk Management” in LGC’s Management’s Discussion and Analysis for the fiscal year ended September 30, 2016, as filed on SEDAR (www.sedar.com). The cautionary statements qualify all forward-looking statements attributable to LGC and persons acting on its behalf. Unless otherwise stated, all forward-looking statements speak only as of the date of this press release and neither LGC nor Global Canna Labs Limited has any obligation to update such statements, except to the extent required by applicable securities laws.

Caution Regarding Press Releases

Neither the TSX Venture Exchange nor its Regulation Service Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

CEMATRIX Corporation Announces Renewed Lafarge Commitment

Calgary, Alberta – January 23, 2018: CEMATRIX Corporation (TSXV: CVX) (the “Corporation” or “CEMATRIX”) announces that Lafarge Canada Inc (“Lafarge”) has re-affirmed a strengthened commitment to CEMATRIX, including “increased sales and marketing support” for the development of cellular concrete markets across Canada.

“It’s important to note for our investors that the Lafarge/CEMATRIX agreement is a clear indication of Lafarge’s belief in the substantial potential of cellular concrete and the mutual benefits that can accrue to both parties.” stated Jeff Kendrick, CEMATRIX President and CEO.

“The overall objective of the agreements for both parties continues to be to work together to increase sales of cellular concrete, which in turn results in the sale of more cement and ready mix products for Lafarge. Although the joint efforts did not generate a significant number of new sales in 2017, both parties believe that we accomplished a great deal together, in the education of the market and Lafarge’s significant staff across Canada on the uses and benefits of Cellular Concrete. We also learned that the regional approach, although successful, has not worked as intended, but that recent changes to that program by both parties, should generate even stronger results, and become a model for expansion into other regions across Canada.”

This continued commitment from Lafarge was stated in a recent letter to CEMATRIX from Lafarge. A few of the excerpts from this commitment letter are as follows:

As 2018 begins, I’d like to take the opportunity to reflect on the Lafarge/CEMATRIX relationship in 2017.  Foremost, Lafarge remains committed to our Joint Marketing and Regional Expansion Agreements struck in 2016 and 2017 respectively.  We have now completed another valuable year of learning together about the implementation mechanisms for those agreements.

Furthermore, the co-development of the Prairie Region remains a priority. Changes for 2018 will include increased sales and marketing support as well as support for the hiring of a dedicated salesperson for this region. The continued successful development of this region will then become a model for expansion to other regions in Canada.

While 2017 did not deliver the intended financial results, Lafarge is pleased with the growing strength and breadth of our relationship.  This foundation is key to a win-win partnership in 2018.

This is very good news for CEMATRIX, as is the fact that contracted and verbally awarded projects for 2018 are now approximately $10.9 million, of which approximately $4.8 million are under contract. This is 48% ahead of the same time, the previous year.

CEMATRIX is an Alberta corporation with its head offices in Calgary, Alberta. The Corporation, through its wholly-owned subsidiary, is a rapidly growing company that manufactures and supplies technologically advanced cellular concrete products developed from proprietary formulations. This unique cement-based material with superior thermal protection, delivers a cost-effective, innovative solution to a broad range of problems facing the infrastructure, industrial (including oil and gas) and commercial markets.

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

For further information, please contact:

Jeff Kendrick – President and Chief Executive Officer
Phone: (403) 219-0484

Jeff Walker – The Howard Group – Investor Relations
Phone: (888) 221-0915 or (403) 221-0915
jeff@howardgroupinc.com

Forward-looking information: This news release contains certain information that is forward-looking and is subject to important risks and uncertainties (such statements are usually accompanied by words such as “anticipate”, expect”, “would’ or other similar words). Forward-looking statements in this document are intended to provide CEMATRIX security holders and potential investors with information regarding CEMATRIX and its subsidiaries’ future financial and operations plans and outlook. All forward-looking statements reflect CEMATRIX’s beliefs and assumptions based on information available at the time the statements were made. Readers are cautioned not to place undue reliance on this forward-looking information. CEMATRIX undertakes no obligation to update or revise forward-looking information except as required by law. For additional information on the assumptions made and the risks and uncertainties which may cause actual results to differ from the anticipated results, refer the CEMATRIX’s Management Discussion and Analysis dated November 16, 2017 under CEMATRIX’s profile on SEDAR at www.sedar.com and other reports filed by CEMATRIX with Canadian securities regulators.

LGC Capital to Increase Strategic Interest in Australian Medical Cannabis Company – Little Green Pharma

  • LGC to increase its strategic interest in Australian Medical Cannabis company Little Green Pharma to 14.99% by issuing 5,000,000 LGC shares.
  • Australian Government to allow the export of medicinal cannabis exports.

MONTREAL, Jan. 22, 2018 – LGC Capital Ltd. (TSXV: LG) (LGCis pleased to announce that it has entered into a Binding Term Sheet with licenced Australian Medical Cannabis company Habi Pharma Pty Ltd of Perth, Australia, doing business as Little Green Pharma (“Little Green Pharma“), to increase LGC’s strategic interest in Little Green Pharma from 11.91% to 14.99%.

The proposed increase to 14.99% will take LGC’s interest in Little Green Pharma to just below the 15% threshold requiring approval from the Australian Foreign Investment Review Board.

Increasing LGC’s interest in Little Green Pharma has been a top priority for LGC over the past few months, and even more so since the Australian Government announced on January 4, 2018 an important step for the development of the Australian medical cannabis sector by permitting the export of medicinal cannabis products from Australia.

The full statement from the Hon. Greg Hunt MP, Australian Minister for Health, is set out below and is also available at:
http://www.health.gov.au/internet/ministers/publishing.nsf/Content/health-mediarel-yr2018-hunt003.htm

Australian Government to allow medicinal cannabis exports (4 January 2018)

In an important step for the development of the medicinal cannabis sector and to secure long-term supplies for Australian patients, the Federal Government will permit the export of medicinal cannabis products.

This follows extensive consultation that was undertaken last year.

Our top priority is to ensure a safe quality supply of medicinal cannabis for Australian patients.

This decision will help both the domestic supply and Australian producers by strengthening the opportunities for domestic manufacturers.

The Turnbull Government is committed to ensuring a safe, quality supply of medicinal cannabis is available to Australian patients under proper medical supervision.

In an additional move to support both patients and manufacturers, the Turnbull Government will now permit the export of Australian manufactured medicinal cannabis products.

We are making these changes because the expanding domestic medicinal cannabis products industry is facing increasing competition from imports.

And allowing the export of medicinal cannabis products will help the developing domestic market to grow further.

We believe it is appropriate to amend the regulations governing the export of cannabis products to provide a level playing field.

But this change will not come at the expense of Australian patients.

In fact, by helping the domestic manufacturers to expand, this in turn helps to ensure an ongoing supply of medicinal cannabis products here in Australia.

It will be a condition of any licence authorising export that medicinal cannabis products be made available, when and if required, to Australian patients first.

Exports were not initially allowed in the scheme because Australia was focussed on gaining the confidence of the international community in its cultivation system and other controls.

I’m pleased that the International Narcotics Control Board reported favourably on Australia’s framework in its 2016 Annual Report.

We are continuing to make it easier for doctors to access medicinal cannabis products more rapidly, while maintaining strict safeguards for individual and community safety.

We want a robust Australian medicinal cannabis industry so that doctors have safe, quality domestic products that they can confidently prescribe to their patients.

Doctors can apply under the Therapeutic Goods Administration’s Special Access Scheme Category or via an Authorised Prescriber to legally prescribe medicinal cannabis products.”

John McMullen, CEO of LGC commented, “The recent changes in Australian Government policy to allow companies like Little Green Pharma to export medical cannabis outside of Australia significantly changes the importance of this investment within the LGC global footprint portfolio. We have worked diligently through the highly-regulated Australian environment for the cannabis sector and have gained approval from the Australian Government’s Office of Drug Control to allow LGC to increase our shareholding above 5%. We are also looking forward to Little Green Pharma producing its first medical cannabis products for commercial sale over the next few months. We are also working closely with Little Green Pharma to provide access to other investee companies within LGC’s portfolio to cross-pollinate growing, facilities, processing and marketing ideas to broaden Little Green Pharma’s reach into potential international markets.”

Fleta Solomon, Little Green Pharma’s Managing Director commented; “We are thrilled that LGC has decided to increase its investment in Little Green Pharma to 14.99% and strengthen its position as a key cornerstone investor. With the Federal Health Minister recently announcing Australia’s potential to be the world’s number one medicinal cannabis supplier, LGC can strategically assist Little Green Pharma in its export and growth opportunities.”

The new Binding Term Sheet will increase LGC’s strategic shareholding in Little Green Pharma to an aggregate of 9,783,495 shares, representing a 14.99% interest. To that end, Little Green Pharma will issue 2,283,495 additional shares to LGC at a deemed issue price of AUD $1.16398 per share for a total consideration of approximately AUD $2,657,950. LGC will pay for the shares by issuing 5,000,000 LGC shares to Little Green Pharma at a deemed issue price of CAD $0.53 per share, representing the closing price of LGC’s shares on the TSX Venture Exchange on Friday, January 19, 2018, for a total consideration of CAD $2,650,000, equivalent to AUD $2,657,950 based on the Bank of Canada exchange rate on January 19, 2018.

The Binding Term Sheet also contains an undertaking by LGC to participate in Little Green Pharma’s next capital raise, by June 30, 2018, to the extent required to maintain LGC’s 14.99% shareholding in Little Green Pharma.

Closing of the transaction with Little Green Pharma is subject to the parties entering into a definitive subscription agreement and to standard closing conditions. The transaction is also subject to regulatory approval, including that of the TSX Venture Exchange.

Note: On January 19, 2017, the Bank of Canada’s daily average exchange rate for the Australian dollar was AUD $1.00 = CAD $0.9970.

About Little Green Pharma (www.lgpharma.com.au)
Little Green Pharma is a private entity in Australia and is one of the few companies in Australia to be granted a licence to cultivate and produce Medical Cannabis within Australia. On December 14, 2017, Little Green Pharma announced that its first crop of medicinal cannabis was being cultivated in Western Australia at its secure growing facility south of Perth. That event marks the first time medicinal cannabis has been cultivated locally in Western Australia. Little Green Pharma aims to have first product available for patients within the first few months of 2018.

About LGC (http://www.lgc-capital.com)
LGC Capital Ltd. is a Canadian incorporated public company listed on the TSX Venture Exchange (TSXV: LG). LGC’s objective is to become a diversified business group with core business divisions that provide shareholders with exposure to a diverse range of businesses, products and services.

Information Relating to Little Green Pharma
All information contained in this press release relating to Little Green Pharma has been provided to LGC by Little Green Pharma. LGC has relied upon this information without having made independent inquiries as to its accuracy or completeness and assumes no responsibility for any inaccuracy or incompleteness of such information.


For further information:

Company Contacts:
Canada Contact:
John McMullen, Chief Executive Officer
Tel: +1(416) 803-0698
Email: John@lgc-capital.com

London contact:
Anthony Samaha, Chief Financial Officer
Tel.: +44 (0) 20 7440 0640

Investor Relations contact:
The Howard Group Inc.
Dave Burwell, Vice President
Tel: +1(403) 221-9015
Toll-Free in Canada: 1-888-221-0915,
Email: dave@howardgroupinc.com

FORWARD-LOOKING STATEMENTS
This press release may contain forward-looking statements with respect to LGC Capital Ltd. (“LGC”) and Habi Pharma Pty Ltd (“Habi Pharma”), and their respective operations, strategy, investments, financial performance and condition. These statements generally can be identified by use of forward- looking words such as “may”, “will”, “expect”, “estimate”, “anticipate”, “intends”, “believe” or “continue” or the negative thereof or similar variations. The actual results and performance of LGC and Habi Phama could differ materially from those expressed or implied by such statements. Such statements are qualified in their entirety by the inherent risks and uncertainties surrounding future expectations. Some important factors that could cause actual results to differ materially from expectations include, among other things, general economic and market factors, competition, government regulation and the factors described under “Risk Factors and Risk Management” in LGC’s Management’s Discussion and Analysis for the fiscal year ended September 30, 2016, as filed on SEDAR (www.sedar.com). The cautionary statements qualify all forward-looking statements attributable to LGC and persons acting on its behalf. Unless otherwise stated, all forward-looking statements speak only as of the date of this press release and neither LGC nor Habi Pharma has any obligation to update such statements, except to the extent required by applicable securities laws.

Caution Regarding Press Releases
Neither the TSX Venture Exchange nor its Regulation Service Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

LGC Launches Initiative to Establish Global Cannabis Blockchain Platform

Highlights
  • LGC is implementing a strategy to create a new workable and transparent global cannabis supply chain platform.
  • The platform will be aimed at enabling a global transparent payment record for cannabis product, supply and payment.
  • The goal is to provide a new efficient platform that can be used for regulatory compliance purposes with government entities, give assurance to consumers on product sourcing and quality, and offer an efficient and compliant payment infrastructure for producers and retailers.
  • LGC is planning to use blockchain technology to provide a reliable and global supply chain register and smart contract framework, and to use Internet of Things (“IOT”) technologies to track physical product across the supply chain.

MONTREAL, Jan. 16, 2018 – LGC Capital Ltd. (TSXV: LG) (LGC) is pleased to announce that it is launching a new subsidiary company to specifically engage in the development of an efficient global marketplace technology platform designed to help producers, value-added processors and retailers in selling, and consumers in accessing, cannabis product. LGC will focus on providing a traceable and verifiable platform, thereby enabling producers to have an efficient payment mechanism that replaces current ad hoc cash-based payments and that will be fully compliant with all relevant jurisdictional regulations.

The platform will utilize the latest blockchain technologies to create a reliable and verifiable purchase and payment system and use Internet of Things (“IOT”) technologies to track cannabis product shipments so as to provide assurance to consumers regarding the sourcing and quality of products.

John McMullen, CEO of LGC states, “LGC is rapidly growing its legal cannabis footprint around the world with each country having its own regulatory framework, transparency and banking challenges that all need addressing as the industry expands and matures. We at LGC recognize these growing business demands, not only for our own operations, but also for other sector participants. We intend to launch a unique and “industry-specific” blockchain / IOT technology platform intended to address the specific needs of many cannabis operators. We will engage with a number of European institutional and technology groups that are highly experienced and knowledgeable in this space and will actively seek institutional co-investments in this venture prior to launching it.”

LGC Global Cannabis Marketplace Platform Initiative

As a fast-growing globally focused investment company with expertise in the cannabis supply chain, LGC is well placed to combine its capital resources and expertise in order to develop a global e-commerce framework to support the legal cannabis industry and to ensure it is integrated with the global banking system in a manner that is compliant with international and local regulations.

Many global technology companies as well as niche IOT and blockchain companies are advancing technology solutions to address the challenges outlined above. LGC intends to engage with industry and technology stakeholders to develop and deliver a global industry solution through a combination of its partnerships and access to capital.

LGC will work to develop an open-sourced framework-based distributed ledger, smart contracts and IOT designed to provide a business framework and supporting technology stack that can be used by producers, value-added processors, retailers and consumers in the cannabis sector.

Over the short to medium term, LGC intends to release a whitepaper for industry comment. This whitepaper will seek global consensus within the cannabis industry. In parallel, LGC intends to establish technology partnerships with key blockchain and IOT companies and systems integrators to implement the recommendations of the whitepaper when industry consensus has been achieved.

Global Marketplace Platform for Cannabis Consumers and Producers

As the cannabis industry moves from a niche and often prohibited industry to a more globally accepted and approved regulated industry, it faces a number of challenges that it will need to overcome in order to achieve broad adoption:

  • Payment companies are providing limited payment capabilities, often requiring the legal cannabis supply chain to resort to cash-based transactions.
  • The lack of a convenient payment infrastructure limits consumer and retailer adoption.
  • Many global banking institutions are disinclined to support cannabis-related companies, thereby limiting them in raising growth capital and causing significant audit and regulatory issues.
  • Lack of reliable accounting and transaction recording due to the cash nature of the business can lead to “bad actors” engaging in the legal cannabis market.
  • Lack of appropriate e-commerce infrastructure limits advertising and consumption and thus market growth potential.
  • Lack of clear physical tracking capabilities and transparent and reliable records significantly limits consumer confidence in product sourcing and quality.

LGC intends to use blockchain and IOT technologies in order to create a global marketplace platform that will provide a state-of-the-art multi-channel (web, tablet, voice and smartphone based) e-commerce framework designed to assist producers, value-added processors, retailers and consumers in addressing the challenges described above.

Role of Blockchain

Blockchain, Smart Contract and Distributed Ledger Technologies such as Ethereum are transforming many industries and payment systems. Stakeholders increasingly realize the efficiencies and cost effectiveness of blockchain in areas like supply chain management. The use of a common and transparent ledger will provide a tool for them to quickly see the benefits of greater visibility, which in turn will lead to superior reconciliation, auditability and regulatory compliance.

Consumers would gain greater assurance of provenance and traceability of products. Non-compliant products can therefore be quickly identified in terms of source, quality, delivery process and history.

Role of IOT

IOT is gaining rapid mainstream adoption. Sensor technology is becoming exponentially less expensive so that sensors can be widely deployed in all cannabis product packages. In addition, the roll-out of global IOT networks enables efficient global tracking of both high-value and low-value shipments. When combined with a global distributed ledger, the basis for verifiable product governance and adherence to government regulations becomes substantially more viable.

LGC’s involvement in the establishment of a global cannabis blockchain platform will be subject to the approval of the TSX Venture Exchange, to the extent applicable.

About LGC (http://www.lgc-capital.com)

LGC Capital Ltd. is a Canadian incorporated public company listed on the TSX Venture Exchange (TSXV: LG). LGC’s objective is to become a diversified business group with core business divisions that provide shareholders with exposure to a diverse range of businesses, products and services.

 


For further information:

Company Contacts:
Canada Contact:
John McMullen, Chief Executive Officer
Tel: +1(416) 803-0698
Email: John@lgc-capital.com

London contact:
Anthony Samaha, Chief Financial Officer
Tel.: +44 (0) 20 7440 0640

Investor Relations contact:
The Howard Group Inc.
Dave Burwell, Vice President
Tel: +1(403) 221-9015
Toll-Free in Canada: 1-888-221-0915,
Email: dave@howardgroupinc.com

FORWARD-LOOKING STATEMENTS
This press release may contain forward-looking statements with respect to LGC Capital Ltd. (“LGC”) and its operations, strategy, investments, financial performance and condition. These statements generally can be identified by use of forward-looking words such as “may”, “will”, “expect”, “estimate”, “anticipate”, “intends”, “believe” or “continue” or the negative thereof or similar variations. The actual results and performance of LGC could differ materially from those expressed or implied by such statements. Such statements are qualified in their entirety by the inherent risks and uncertainties surrounding future expectations. Some important factors that could cause actual results to differ materially from expectations include, among other things, general economic and market factors, competition, government regulation and the factors described under “Risk Factors and Risk Management” in LGC’s Management’s Discussion and Analysis for the fiscal year ended September 30, 2016, as filed on SEDAR (www.sedar.com). The cautionary statements qualify all forward-looking statements attributable to LGC and persons acting on its behalf. Unless otherwise stated, all forward-looking statements speak only as of the date of this press release and LGC does not have any obligation to update such statements, except to the extent required by applicable securities laws.

Caution Regarding Press Releases
Neither the TSX Venture Exchange nor its Regulation Service Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

 

LGC Launches JV Company with Creso Pharma and Baltic Beer Company toCapitalize on Growing Cannabis-Derived Beverage Market

Highlights:

  • Formal launch of joint venture company, CLV Frontier Brands Pty Ltd (CLV), which plans to develop and globally commercialize a premium portfolio of alcoholic and non-alcoholic beverages with cannabis and hemp ingredients.
  • CLV on target to ship first test batch of the initial beer range in April / May 2018, with commercial sales expected to commence in June / July 2018.
  • Worldwide commercialization will span various continents tapping in on the networks of all three companies. Large network of distribution partners already identified.

MONTREAL, Jan 11, 2018 – LGC Capital Ltd. (TSXV: LG) (LGC) is pleased to announce that it has formally launched its new joint venture company with Creso Pharma Limited (ASX: CPH) and Baltic Beer Company Ltd to capitalize on the fast-growing cannabis and hemp-derived beverage markets.

The joint venture company – CLV Frontier Brands Pty Ltd (“CLV”) – will develop and globally commercialize a premium portfolio of cannabis and hemp-derived alcoholic and non-alcoholic beverages containing various ingredients, seeds, extracts and terpenes from hemp and cannabis plants.

The launch of CLV follows the announcement in November 2017 of a binding letter of intent among the three parties and the formation of the joint venture company.

CLV is currently developing an initial premium four-beer range containing unique cannabis terpene mixes as well as other innovative ingredients. CLV also intends to create a vegan line of beverages for consumers who demand this option. These unique terpenes will carry the flavour and aroma of cannabis and will provide a sensual cannabis experience, but will not contain THC or CBD or any other cannabinoids.

Each of LGC, Creso Pharma and Baltic Beer will have a one-third interest in CLV. LGC’s involvement in the joint venture is subject to the approval of the TSX Venture Exchange.

Initial Test Batch Shipment and Global Commercial Launch on Track

CLV is currently on target to ship the first test batch of an initial four-beer range containing cannabis-derived terpenes in April / May 2018, with commercial sales expected to commence in June / July 2018.

CLV has already identified potential distribution partners in Europe, far East Asia, Central and Latin America, Canada, Africa, Australia and New Zealand and also plans to expand its portfolio into other alcoholic and non-alcoholic beverages over time.

CLV intends to establish a pilot R&D brewing facility in Tallinn, Estonia which will be dedicated to working on innovative recipes and developing proprietary know-how and IP which will be registered by the joint venture. CLV will distribute and market products strictly in compliance with all local laws.

Global Market Opportunity

The launch of CLV comes at a time when there is growing interest in the cannabis and hemp-derived beverage market, which is experiencing strong growth.

In October 2017, global beverage conglomerate Constellation Brands (NYSE: STZ) took a 9.9% stake in cannabis group, Canopy Growth, for a total of US$200 million in order to develop and market cannabis-infused drinks[1].

Meanwhile, the global craft beer market is predicted to grow at a compound annual growth rate (CAGR) of 11.04% between 2017 and 2021[2], with the European, Middle East and African markets expected to reach US$38.36 billion in 2021. The craft beer market in the APAC region is also growing strongly at a CAGR of 16.14%.

Source: https://www.businesswire.com/news/home/20170811005227/en/Global-Craft-Beer-Market—Geographical-Segmentation

CLV

CLV’s Board comprises LGC’s President and Chief Executive Officer John McMullen, Creso Pharma’s Chief Executive Officer Dr. Miri Halperin Wernli, and Baltic Beer Company Director Alex Klaos, whose role will be to oversee the day-to-day operations of CLV to ensure product development, growth targets and distribution reach are achieved.

John McMullen, CEO of LGC states, “LGC immediately recognized the potential of this joint venture, while working with Creso Pharma and Baltic Beer Company, to plan the development and commercialization of our new innovative products. We are very confident that the beverages that are developed through this joint venture will be well received. The worldwide commercialization plan is aggressive and I fully expect it will have a positive impact on the revenue stream for all parties involved.”

Dr. Miri Halperin Wernli, CEO of Creso Pharma states, “We are a global leader in cannabis innovation, developing hemp and cannabis derived therapeutic and lifestyle products and are committed to becoming a leading global player in the cannabis space through disruptive efficiency and innovation. Our approach is to partner with industry and technology leaders to develop and commercialize innovative products which will capture the consumers’ senses and imagination. Entering the cannabis derived beverages market exemplifies this approach and will build on our scientific and technical expertise as well as on our vast geographical reach for commercialization.”

What are terpenes?

Cannabis terpenes are fragrant oils that give cannabis its aromatic diversity

  • They are what give Blueberry its signature berry smell and Lavender its sweet floral aroma.
  • At least 200 terpenes have been identified in cannabis and these molecules are potent and believed to affect both animal and human behaviour.
  • These oils are secreted in the flower’s sticky resin glands, the same ones that produce THC, CBD and other cannabinoids.
  • Like cannabinoids, terpenes bind to receptors in the brain and give rise to various effects.
  • As flavouring agents, terpenes raise no safety concerns. They are Generally Recognized As Safe (“GRAS”) as attested by the U.S. Food and Drug Administration (FDA) classifying them as food additives, and by the Food and Extract Manufacturers Association and other world regulatory bodies classifying them as Safe (see WHO1/ FEMA GRAS2).

About LGC (http://www.lgc-capital.com)

LGC Capital Ltd. is a Canadian incorporated public company listed on the TSX Venture Exchange (TSXV: LG). LGC’s objective is to become a diversified business group with core business divisions that provide shareholders with exposure to a diverse range of businesses, products and services.

About Creso Pharma (www.cresopharma.com)

Creso Pharma is bringing the best of Cannabis to better the lives of people and animals. Creso brings pharmaceutical expertise and methodological rigour to the world of medicinal cannabis and strives for the highest quality in its products. It is a global leader in medicinal cannabis and cannabidiol (CBD) innovation and developing cannabis and hemp-derived therapeutic-grade CBD nutraceuticals and medicinal cannabis products with wide patient reach for human and animal health. Creso uses GMP development and manufacturing standards for its products as a reference of quality excellence with initial product registrations in Switzerland. Creso has worldwide rights for a number of unique and proprietary innovative delivery technologies which enhance the bioavailability and absorption of cannabinoids.

About Baltic Beer Company Ltd (www.virubeer.com)

A UK based company that created and markets an iconic Estonian beer brand called Viru Premium Estonian Beer. Viru beer is currently sold in numerous markets around the world including Australia, China, UK, Italy and Mexico to name a few and has won multiple awards including gold medals at Monde Selection, Brussels and the World Beer Championships Chicago.

[1] https://www.eater.com/2017/10/30/16575412/constellation-brands-cannabis-beverages-investment


For further information:

Company Contacts:
Canada Contact:
John McMullen, Chief Executive Officer
Tel: +1(416) 803-0698
Email: John@lgc-capital.com

London contact:
Anthony Samaha, Chief Financial Officer
Tel.: +44 (0) 20 7440 0640

Investor Relations contact:
The Howard Group Inc.
Dave Burwell, Vice President
Tel: +1(403) 221-9015
Toll-Free in Canada: 1-888-221-0915,
Email: dave@howardgroupinc.com

FORWARD-LOOKING STATEMENTS
This press release may contain forward-looking statements with respect to LGC Capital Ltd. (“LGC”) and CLV Frontier Brands Pty Ltd (“CLV”), and their respective operations, strategy, investments, financial performance and condition. These statements generally can be identified by use of forward- looking words such as “may”, “will”, “expect”, “estimate”, “anticipate”, “intends”, “believe” or “continue” or the negative thereof or similar variations. The actual results and performance of LGC and CLV, and of the joint venture described herein, could differ materially from those expressed or implied by such statements. Such statements are qualified in their entirety by the inherent risks and uncertainties surrounding future expectations. Some important factors that could cause actual results to differ materially from expectations include, among other things, general economic and market factors, competition, government regulation and the factors described under “Risk Factors and Risk Management” in LGC’s Management’s Discussion and Analysis for the fiscal year ended September 30, 2016, as filed on SEDAR (www.sedar.com). The cautionary statements qualify all forward-looking statements attributable to LGC and persons acting on its behalf. Unless otherwise stated, all forward-looking statements speak only as of the date of this press release and neither LGC nor CLV has any obligation to update such statements, except to the extent required by applicable securities laws.

Caution Regarding Press Releases
Neither the TSX Venture Exchange nor its Regulation Service Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

 

LGC Capital Clarifies it is an Investor in the Global Cannabis Market, Excluding the United States

MONTREAL, January 5, 2018 – LGC Capital Ltd. (TSXV: LG) (“LGC”) wishes to comment on the directive issued yesterday by the United States Justice Department that will allow the enforcement of U.S. federal marijuana laws in those states that have legalized cannabis.

John McMullen, CEO of LGC stated: “As a Canadian, I have full respect for the United States Government. Yesterday’s directive by the U.S. Justice Department will unfold over time. That being said, I wish to remind our shareholders that LGC expressly has no current, nor expects to have, commitments to any cannabis investments in the United States. LGC’s portfolio is comprised only of investments in jurisdictions worldwide in which cannabis is or will shortly be legal, excluding the United States. 

We as an executive team and Board realize the future importance of medical cannabis products for the global consumer. Through our investment in Little Green Pharma, we are pleased with the recent decision of the Australian government to consider global export.

LGC also looks forward to the Canadian Government’s expansion of its legislative mandate to legalize cannabis further with the approval for recreational consumption. LGC’s pending investment in Quebec is both exciting and, we believe, will add to our potential returns.

We at LGC believe proudly in our direction and will diligently continue forward with our partners in Australia, Canada and Switzerland. Our partners in Southern Africa continue to excel in their goals as well. We recognize the potential for Southern Africa to grow and supply a large percentage of the world’s high-quality cannabis demand.

The global cannabis market is expected to reach at approximately $70 – $75 billion by 2025(1) and there are consumers who demand quality products. We are excited about LGC’s potential to deliver to those people.

We will update our shareholders and the markets in a timely manner as we deliver on our global mandates outside of the United States.”

(1) http://420intel.com/articles/2017 /12/12/canadian-innovations-cultivate-quality-cannabis-explosive-global-marijuana

About LGC Capital Ltd. www.lgc-capital.com
LGC Capital Ltd. is a Canadian incorporated public company listed on the TSX Venture Exchange (TSXV: LG). LGC’s objective is to become a diversified business group with core business divisions that provide shareholders with exposure to a diverse range of businesses, products and services.


For further information:

Company Contacts:
Canada Contact:
John McMullen, Chief Executive Officer
Tel: +1(416) 803-0698
Email: John@lgc-capital.com

London contact:
Anthony Samaha, Chief Financial Officer
Tel.: +44 (0) 20 7440 0640

Investor Relations contact:
The Howard Group Inc.
Dave Burwell, Vice President
Tel: +1(403) 221-9015
Toll-Free in Canada: 1-888-221-0915,
Email: dave@howardgroupinc.com

FORWARD-LOOKING STATEMENTS
This press release may contain forward-looking statements with respect to LGC Capital Ltd. (“LGC”), its operations, strategy, investments, financial performance and condition, and the Investment Agreement referred to above. These statements generally can be identified by use of forward-looking words such as “may”, “will”, “expect”, “estimate”, “anticipate”, “intends”, “believe” or “continue” or the negative thereof or similar variations. The actual results and performance of LGC could differ materially from those expressed or implied by such statements. Such statements are qualified in their entirety by the inherent risks and uncertainties surrounding future expectations. Some important factors that could cause actual results to differ materially from expectations include, among other things, general economic and market factors, competition, government regulation and the factors described under “Risk Factors and Risk Management” in LGC’s Management’s Discussion and Analysis for the fiscal year ended September 30, 2016, as filed on SEDAR (www.sedar.com). The cautionary statements qualify all forward-looking statements attributable to LGC and persons acting on its behalf. Unless otherwise stated, all forward-looking statements speak only as of the date of this press release and LGC has no obligation to update such statements, except to the extent required by applicable securities laws.

Caution Regarding Press Releases
Neither the TSX Venture Exchange nor its Regulation Service Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

 

Permex Petroleum Corporation Files Preliminary Prospectus for Initial Public Offering led by Canaccord Genuity and including Gravitas Securities

Vancouver, British Columbia – January 5, 2018: Permex Petroleum Corporation (the “Corporation“) is pleased to announce that it has filed a preliminary prospectus (the “Prospectus“) with the securities regulatory authorities in each of the provinces of British Columbia, Alberta, Saskatchewan and Ontario in connection with the proposed initial public offering (the “Offering“) of the Corporation’s common shares (the “Shares“). The Offering consists of a minimum of 5,000,000 Shares for gross proceeds of $2,500,000 and a maximum of 20,000,000 Shares for gross proceeds of $10,000,000.

The Offering is being made on a commercially reasonable efforts basis through a syndicate of agents led by Canaccord Genuity Corp. and including Gravitas Securities Inc. (collectively, the “Agents“).

There can be no assurance that the Offering will be completed. An investment in the Shares is subject to a number of risks. For more information, potential investors should read the Prospectus, including the risk factors described in the Prospectus, which is available from the Agents and on SEDAR at www.sedar.com. The Prospectus has not yet become final for the purpose of a distribution to the public. This press release does not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale or acceptance of an offer to buy the Shares in any jurisdiction in which such offer, solicitation or sale would be unlawful.

United States Advisory

This press release is not for distribution, directly or indirectly, in or into the United States (including its territories and possessions, any state of the United States and the District of Columbia) or any other jurisdiction outside Canada. This press release does not constitute or form part of any offer or solicitation to buy or sell any securities in the United States or any other jurisdiction outside of Canada. The securities offered pursuant to the Prospectus have not been and will not be registered under the United States Securities Act of 1933, as amended (the “U.S. Securities Act”) or any U.S. state securities laws and may not be offered or sold in the United States or to U.S. Persons absent registration or an available exemption from the registration requirements of the U.S. Securities Act and applicable U.S. state securities laws. There will be no public offering of securities in the United States.

About Permex Petroleum Corporation

Permex Petroleum Corporation is a junior oil and gas company with a focus on identifying, evaluating and acquiring oil and natural gas assets in North America and enhancing and developing its currently held oil and natural gas assets in the State of Texas and the State of New Mexico.


CONTACT INFORMATION

Permex Petroleum Corporation
Mehran Ehsan
President & Chief Executive Officer
(604) 259-2525

Or for Investor Relations please contact:
The Howard Group Inc.
Dave Burwell
Tel: +1(403) 221-9015
Toll Free in Canada: 1-888-221-091

No securities regulatory authority has either approved or disapproved of the contents of this press release.

LGC Capital Ltd. Enters Into US $2.34 Million Convertible Loan Agreement To Fund 2018 Expansion

Montreal, Québec – January 2, 2018 – LGC Capital Ltd. (TSXV: LG) (“LGC”) is pleased to announce that it has entered into an Investment Agreement with international investors YA II PN, Ltd and Cuart Investments PCC Limited pursuant to which they will loan LGC an aggregate amount of US $2.34 million (approximately CAD $2.94 million). LGC intends to use the net proceeds from the loan to further advance its core business divisions on its global platform.

John McMullen, CEO of LGC stated: “We thank London institutional group RiverFort Global Capital for its involvement and financial support of LGC’s global initiatives at this exciting time for the Company, as we rapidly expand our cannabis investment businesses. This funding will further secure LGC’s rapidly-developing platforms within the cannabis space. For a Canadian company to attract additional funding from an international group such as RiverFort speaks volumes for the work accomplished by LGC and our objectives for 2018.”

The loan will have a term of twelve months and bear interest at an annual rate of 12%. LGC will pay the interest on the date on which funds are advanced to it through the issuance of shares to the lenders at a price per share equal to the market price of LGC’s shares on the TSX Venture Exchange
at the time of the advance.

The principal amount of the loan will be convertible into LGC common shares at the option of the lenders at a price per share equal to the lesser of (i) US $0.538 (CAD $0.675), representing the US dollar equivalent of 135% of the closing price of LGC’s shares on the TSX Venture Exchange on December 29, 2017 (CAD $0.50), and (ii) 90% percent of the lowest daily volume weighted average trading price of LGC’s shares during the five trading days immediately preceding the date of a conversion notice from the lenders, subject to a minimum conversion price of CAD $0.50.

Upon each advance of funds under the Investment Agreement, LGC will issue common share purchase warrants to the lenders in an amount equal to 25% of the dollar amount of the advance divided by CAD $0.4465, being the volume weighted average trading price of LGC’s shares during the five trading days ended December 29, 2017. Each warrant will entitle its holder to acquire one common share of LGC at a price of CAD $0.70, representing 140% of LGC’s closing price on December 29, 2017, for a period of one year from the date of issuance.

In connection with the Investment Agreement, LGC will pay a structuring fee to RiverFort Global Capital Ltd. of London, England by issuing shares to it in an amount equal to 10% of the dollar amount of any advance divided by CAD $0.675, representing 135% of the closing price of LGC’s shares on the TSX Venture Exchange on December 29, 2017 (CAD $0.50). Fifty percent of the shares will be issued on the date of the advance while fifty percent will be issued on the repayment date of the loan, subject to the condition that if the lenders convert more than half of the amount advanced to LGC on an aggregate basis at a price per share equal to or greater than US $0.538, representing the US dollar equivalent of 135% of the closing price of LGC shares on December 29, 2017 (CAD $0.50), LGC will not be required to issue the second fifty percent of the shares. LGC will also pay a cash due diligence fee to RiverFort Global Capital Ltd.

The Investment Agreement contains standard representations, warranties and covenants of the parties. Closing of the transaction and the advance of funds to LGC is expected to take place on or before January 31, 2018, subject to standard closing conditions. The Investment Agreement, including all issuances of shares by LGC pursuant thereto, is subject to the approval of the TSX Venture Exchange. Any securities issued by LGC at the closing of the transaction, as well as any shares issued upon conversion of the loan or upon the exercise of warrants, will be subject to restrictions on resale for a period of four months from the closing date of the transaction. LGC is at arm’s length from the lenders and RiverFort Global Capital Ltd.

About LGC Capital Ltd. www.lgc-capital.com
LGC Capital Ltd. is a Canadian incorporated public company listed on the TSX Venture Exchange (TSXV: LG). LGC’s objective is to become a diversified business group with core business divisions that provide shareholders with exposure to a diverse range of businesses, products and services.


For further information:

Company Contacts:
Canada Contact:
John McMullen, Chief Executive Officer
Tel: +1(416) 803-0698
Email: John@lgc-capital.com

London contact:
Anthony Samaha, Chief Financial Officer
Tel.: +44 (0) 20 7440 0640

Investor Relations contact:
The Howard Group Inc.
Dave Burwell, Vice President
Tel: +1(403) 221-9015
Toll-Free in Canada: 1-888-221-0915,
Email: dave@howardgroupinc.com

FORWARD-LOOKING STATEMENTS
This press release may contain forward-looking statements with respect to LGC Capital Ltd. (“LGC”), its operations, strategy, investments, financial performance and condition, and the Investment Agreement referred to above. These statements generally can be identified by use of forward-looking words such as “may”, “will”, “expect”, “estimate”, “anticipate”, “intends”, “believe” or “continue” or the negative thereof or similar variations. The actual results and performance of LGC could differ materially from those expressed or implied by such statements. Such statements are qualified in their entirety by the inherent risks and uncertainties surrounding future expectations. Some important factors that could cause actual results to differ materially from expectations include, among other things, general economic and market factors, competition, government regulation and the factors described under “Risk Factors and Risk Management” in LGC’s Management’s Discussion and Analysis for the fiscal year ended September 30, 2016, as filed on SEDAR (www.sedar.com). The cautionary statements qualify all forward-looking statements attributable to LGC and persons acting on its behalf. Unless otherwise stated, all forward-looking statements speak only as of the date of this press release and LGC has no obligation to update such statements, except to the extent required by applicable securities laws.

Caution Regarding Press Releases
Neither the TSX Venture Exchange nor its Regulation Service Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.